Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica

European Journal of Neurology

Volumn 18, Issue 6, 2011, Pages 836-841

  Chanson, J B ^a   Zephir H ^b   Collongues, N ^a   Outteryck, O ^b   Blanc, F ^a   Fleury, M ^a   Vermersch, P ^b   de Seze, J ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Depression; Fatigue; Neuromyelitis optica; NMO IgG; Quality of life

Indexed keywords

ADULT; ARTICLE; BLADDER FUNCTION; CLINICAL ARTICLE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DISABILITY; DISEASE DURATION; FATIGUE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE FUNCTION; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; VISUAL ACUITY;

ADULT; COMORBIDITY; COST OF ILLNESS; DEPRESSIVE DISORDER; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; SELF REPORT;

EID: 79955737559     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03252.x     Document Type: Article

References (31)

1. The Canadian Burden of Illness Study Group. Burden of illness of multiple sclerosis: part II: quality of life. Can J Neurol Sci 1998; 25: 31-38.
2. Clavelou P, Auclair C, Taithe F, Gerbaud L. Quality of life in Multiple Sclerosis. Rev Neurol (Paris) 2009; 165(HS2): 123-128.
3. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994; 21: 9-14.
4. Bakshi R. Fatigue associated with multiple sclerosis: diagnosis, impact and management. Mult Scler 2003; 9: 219-227.
5. Ziemssen T. Multiple sclerosis beyond EDSS: depression and fatigue. J Neurol Sci 2009; 277(Suppl 1): S37-S41.
6. Radat F, Lafittau M, Ouallet JC, Brochet B, Jouvent R. Validation of EHD self questionnaire in multiple sclerosis. Encephale 2007; 33: 49-57.
7. Miller A, Dishon S. Health-related quality of life in multiple sclerosis: The impact of disability, gender and employment status. Qual Life Res 2006; 15: 259-271.
8. Pittion-Vouyovitch S, Debouverie M, Guillemin F, Vandenberghe N, Anxionnat R, Vespignani H. Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci 2006; 243: 39-45.
9. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
10. Pittock SJ, Mayr WT, McClelland RL, et al. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol 2004; 61: 679-686.
11. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-1114.
12. De Seze J. Neuromyelitis optica. Arch Neurol 2003; 60: 1336-1338.
13. Sellner J, Boggild M, Clanet M, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 2010; 17: 1019-1032.
14. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
15. Vernay D, Gerbaud L, Biolay S, et al. Quality of life and multiple sclerosis: validation of the French version of the self-questionnaire (SEP-59). Rev Neurol (Paris) 2000; 156: 247-263.
16. Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res 1995; 4: 187-206.
17. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
18. Gerbaud L, Deffond D, Mulliez A, Benausse F, Vernay D, Clavelou P. Cognitive impairment and quality of life in multiple sclerosis patients. Rev Neurol (Paris) 2006; 162: 970-979.
19. Perneger TV, Leplège A, Etter JF, Rougemont A. Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF-36) in young healthy adults. J Clin Epidemiol 1995; 48: 1051-1060.
20. Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F. Validity of a French version of the fatigue impact scale in multiple sclerosis. Mult Scler 2007; 13: 1026-1032.
21. Beck AT, Steer R, Garbin M. Psychometric properties of the Beck Depression Inventory: twenty-five years of research. Clin Psychol Rev 1988; 8: 77-100.
22. Flachenecker P, Bihler I, Weber F, Gottschalk M, Toyka KV, Rieckmann P. Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler 2004; 10: 165-169.
23. Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry 2006; 77: 34-39.
24. Pentón-Rol G, Cervantes-Llanos M, Martínez-Sánchez G, et al. TNF-alpha and IL-10 downregulation and marked oxidative stress in Neuromyelitis Optica. J Inflamm (Lond) 2009; 2: 6-18.
25. Uzawa A, Mori M, Ito M, et al. Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis. J Neurol 2009; 256: 2082-2084.
26. Correale J, Fiol M (2004) Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology 63:2363-2670.
27. Brochet B, Deloire MS, Ouallet JC, et al. Pain and quality of life in the early stages after multiple sclerosis diagnosis: a 2-year longitudinal study. Clin J Pain 2009; 25: 211-217.
28. Marignier R, De Sèze J, Vukusic S, et al. NMO-IgG and Devic's neuromyelitis optica: a French experience. Mult Scler 2008; 14: 440-445.
29. Cabrera-Gómez JA, Bonnan M, González-Quevedo A, et al. Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies. Mult Scler 2009; 15: 828-833.
30. Kroencke DC, Lynch SG, Denney DR. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult Scler 2000; 6: 131-136.
31. Ware JE. SF-36 Health Survey: Manual & Interpretation Guide. Boston, Mass: The Health Institute, 1993.